Is your diabetes or obesity drug ready to lead the way?

In the race for GLP-1 agonist therapies, you need to stand out. Leverage expert strategies and precise data to maximize your success.

In our on-demand webinar, learn clinical trial strategies to characterize safety and efficacy, while also generating meaningful data to differentiate your drug.

Enhance your GLP-1 trial success with expertise you can trust 

We offer a robust combination of scientific prowess, advanced technologies, and a proven track record to support your development program, including:

  • Unmatched expertise: Featuring dozens of peer-reviewed manuscripts focused on Type 2 diabetes and obesity drug development
  • Consistent, accurate results: Leverage innovative technologies and workflows to generate precise data you can trust
  • Speed and efficiency: Accelerate study setup and data analysis to enable informed decision-making

Transform your GLP-1 trial with insights from our experts.

Key webinar highlights

Evidence Icon Reverse RGB

Comprehensive assessment

Explore advanced imaging to document therapeutic gains and mitigate risks, ensuring robust regulatory evidence.

Solution Icon Reverse RGB

Innovative solutions

Discover how cutting-edge digital endpoints enhance GLP-1 trial safety, efficacy, and value with high-quality data.

Patient Support Icon Reverse RGB

Real-world differentiation

Learn to differentiate treatments using patient-reported outcomes that showcase real-world impacts on quality of life.

Deliver precise endpoint data and outpace competitors

Overcome the complexities of your GLP-1 trials with our comprehensive clinical trial endpoint solutions. We help with: 

  • Ensuring data consistency and regulatory compliance
  • Selecting and using the right digital endpoints
  • Accessing trusted GLP-1 development expertise
  • Speeding up market entry in a competitive space

Proven results in GLP-1 agonist clinical trials 

Our results speak volumes: 

  • Supported over 170 GLP-1a studies, including all currently FDA approved drugs in class
  • Delivered consistent data leveraging a full range of digital endpoint solutions, characterizing drug safety, efficacy, and patient quality of life
  • Supported over 900 diabetes and weight management clinical trial opportunities

Healthy futures start here

Explore how innovative digital and imaging endpoint strategies can maximize your trial’s value, maintain regulatory compliance, and drive success. Don’t miss this opportunity to learn from industry experts and elevate your GLP-1 clinical trials.